JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB76008

Anti-PARK7/DJ1 antibody [EP2815Y]

5

(4 리뷰들)

|

(51 제품이 사용된 논문 )

Rabbit Recombinant Monoclonal PARK7/DJ1 antibody. Suitable for IHC-P, IP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human, Mouse, Rat samples. Cited in 51 publications.
14 이미지
Immunocytochemistry/ Immunofluorescence - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)

Immunocytochemistry/ Immunofluorescence analysis of Jurkat (Human T cell leukemia T lymphocyte) cells labeling PARK7/DJ1 with Purified ab76008 at 1 : 500 dilution (0.2 μg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1 : 200 (2.5 μg/ml). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1 : 1000 (2 μg/ml) dilution. DAPI nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.

Immunocytochemistry/ Immunofluorescence - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)

Immunocytochemistry/Immunofluorescence analysis of MCF-7 (human breast carcinoma) labelling PARK7/DJ1 with purified ab76008 at 1/500. Cells were fixed with 4% PFA and permeabilized with 0.1% Triton X-100. An Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody (ab150077). Nuclei counterstained with DAPI (blue).

Control : PBS only

This image was generated using the unpurified version of the product.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human lung cancer tissue sections labeling PARK7/DJ1 with Purified ab76008 at 1 : 1000 dilution (0.11 μg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). ImmunoHistoProbe one step HRP Polymer (ready to use)was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.

Immunocytochemistry/ Immunofluorescence - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)
  • ICC/IF

Collaborator

Immunocytochemistry/ Immunofluorescence - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)

ab76008 was shown to react with PARK7 in wild-type HEK-293T cells in immunocytochemistry with loss of signal observed in a PARK7 knockout cell line. Wild-type and knockout cells were mixed and pelleted at a 1 : 1 ratio on coverslips. The cells were fixed with 4% paraformaldehyde (15 min) then permeabilized with 0.1% Triton X-100 (10min) and then blocked with 1x PBS, 0.01% Triton X-100, 5% BSA, 5% NGS. The cells were then incubated with ab76008 at 1/100 dilution overnight at 4°C followed by a further incubation at room temperature for 1h with a goat anti-rabbit secondary antibody to (Alexa Fluor® 555) at 0.5 µg/ml. Acquisition of the green (wild-type), red (antibody staining) and far-red (knockout) channels was performed. Representative grayscale images of the red channel are shown. Wild-type and knockout cells are outlined with yellow and magenta dashed line, respectively. Schematic representation of the mosaic strategy used is shown on the bottom-right panel. Image was acquired with a Zeiss(LSM-880).

This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

Flow Cytometry (Intracellular) - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)

Intracellular Flow Cytometry analysis of HepG2 (Human hepatocellular carcinoma epithelial cell) cells labeling PARK7/DJ1 with Purified ab76008 at 1/20 dilution (10μg/ml) (red). Cells were fixed with 4% Paraformaldehyde. A Goat anti rabbit IgG (Alexa Fluorr® 488, ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).

Flow Cytometry (Intracellular) - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)

Overlay histogram showing HepG2 cells stained with ab76008 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab76008, 1/100 dilution) for 30 min at 22°C. The secondary antibody used was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) (ab150077) at 1/2000 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter. This antibody gave a positive signal in HepG2 cells fixed with 80% methanol (5 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.

This image was generated using the unpurified version of the product.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)

ab76008, at 1/250 dilution, staining PARK7/DJ1 in human brain by immunohistochemistry using paraffin-embedded tissue.

This image was generated using the unpurified version of the product.

Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

Immunoprecipitation - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)
  • IP

Unknown

Immunoprecipitation - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)

ab76008 (purified) at 1 : 20 dilution (0.5μg) immunoprecipitating PARK7/DJ1 in Mouse brain lysate.
Lane 1 (input) : Mouse brain lysate 10μg
Lane 2 (+) : ab76008 & Mouse brain lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab76008 in Mouse brain lysate
For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1 : 1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.

All lanes:

Immunoprecipitation - Anti-PARK7/DJ1 antibody [EP2815Y] (ab76008)

Predicted band size: 20 kDa

false

Western blot - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)
  • WB

Lab

Western blot - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)

All lanes:

Western blot - Anti-PARK7/DJ1 antibody [EP2815Y] (ab76008) at 1/5000 dilution

Lane 1:

HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysates at 15 µg

Lane 2:

Mouse brain lysates at 15 µg

Lane 3:

Rat brain lysates at 15 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 20 kDa

Observed band size: 23 kDa

false

Western blot - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)
  • WB

Unknown

Western blot - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)

This image was generated using the unpurified version of the product.

All lanes:

Western blot - Anti-PARK7/DJ1 antibody [EP2815Y] (ab76008) at 1/20000 dilution

Lane 1:

Jurkat cell lysate at 10 µg

Lane 2:

HeLa cell lysate at 10 µg

Lane 3:

NIH3T3 cell lysate at 10 µg

Lane 4:

293T cell lysate at 10 µg

Secondary

All lanes:

Goat anti-rabbit HRP at 1/1000 dilution

Predicted band size: 20 kDa

Observed band size: 23 kDa

false

Western blot - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)
  • WB

Unknown

Western blot - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)

Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : PARK7/DJ1 knockout HAP1 cell lysate (20 μg)
Lane 3 : HeLa cell lysate (20 μg)
Lane 4 : Human brain tissue lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab76008 observed at 24 kDa. Red - loading control, ab8245, observed at 37 kDa.

ab76008 was shown to specifically react with PARK/DJ1 in wild-type HAP1 cells. No band was observed when PARK/DJ1 knockout samples were used. Wild-type and PARK/DJ1 knockout samples were subjected to SDS-PAGE. ab76008 and ab8245 (loading control to GAPDH) were both diluted 1/10,000 and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10,000 dilution for 1 h at room temperature before imaging.

All lanes:

Western blot - Anti-PARK7/DJ1 antibody [EP2815Y] (ab76008)

Predicted band size: 20 kDa

false

Western blot - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)
  • WB

Collaborator

Western blot - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)

ab76008 was shown to react with PARK7 in wild-type HEK-293T cells in Western blot with loss of signal observed in PARK7 knockout cell line ab266338. Wild-type HEK-293T and PARK7 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab76008 overnight at 4 °C at a 1/5000 dilution. Blots were incubated with secondary antibodies at 0.2 µg/mL before imaging.

This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

All lanes:

Western blot - Anti-PARK7/DJ1 antibody [EP2815Y] (ab76008) at 1/5000 dilution

Lane 1:

Wild-type HEK-293T lysate at 30 µg

Lane 2:

PARK7 knock-out HEK-293T lysate at 30 µg

Lane 2:

Western blot - Human PARK7 (DJ1) knockout HEK-293T cell line (<a href='/ko/products/cell-lines/human-park7-dj1-knockout-hek-293t-cell-line-ab266338'>ab266338</a>) at 30 µg

false

Western blot - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)
  • WB

Lab

Western blot - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)

Lanes 1-4 : Merged signal (red and green). Green - ab76008 observed at 24 kDa. Red - loading control ab8245 observed at 36 kDa.

ab76008 Anti-PARK7/DJ1 antibody [EP2815Y] was shown to specifically react with PARK7/DJ1 in wild-type HEK-293T cells. Loss of signal was observed when knockout cell line ab266338 (knockout cell lysate ab257016) was used. Wild-type and PARK7/DJ1 knockout samples were subjected to SDS-PAGE. ab76008 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-PARK7/DJ1 antibody [EP2815Y] (ab76008) at 1/1000 dilution

Lane 1:

Wild-type HEK-293T (Human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate at 20 µg

Lane 2:

Western blot - Human PARK7 (DJ1) knockout HEK-293T cell lysate (<a href='/ko/products/cell-lysates/human-park7-dj1-knockout-hek-293t-cell-lysate-ab257016'>ab257016</a>) at 20 µg

Lane 3:

HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg

Lane 4:

Human brain nuclear fraction tissue lysate at 20 µg

Secondary

All lanes:

Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution

Predicted band size: 20 kDa

Observed band size: 24 kDa

false

Western blot - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)
  • WB

Lab

Western blot - Anti-PARK7/DJ1 antibody [EP2815Y] (AB76008)

All lanes:

Western blot - Anti-PARK7/DJ1 antibody [EP2815Y] (ab76008) at 1/5000 dilution

All lanes:

Human fetal brain lysates at 15 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution

Predicted band size: 20 kDa

Observed band size: 23 kDa

false

관련 conjugated 항체와 다양한 조성의 항체 (7)

  • Mouse version

    Anti-PARK7/DJ1 antibody [EP2815Y] - Mouse IgG1 (Chimeric) - BSA and Azide free

  • Mouse version

    Anti-PARK7/DJ1 antibody [EP2815Y] - Mouse IgG1 (Chimeric)

  • Carrier free

    Anti-PARK7/DJ1 antibody [EP2815Y] - BSA and Azide free

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-PARK7/DJ1 antibody [EP2815Y]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-PARK7/DJ1 antibody [EP2815Y]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-PARK7/DJ1 antibody [EP2815Y]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-PARK7/DJ1 antibody [EP2815Y]

주요 정보

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP2815Y

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

Flow Cyt (Intra), WB, IHC-P, ICC/IF, IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/1000", "IHCP-species-notes": "<p>Perform heat mediated antigen retrieval using 0.01M Sodium Citrate Buffer, pH 6.0 before commencing with IHC staining protocol.</p><p><strong>For unpurified use at 1/250 - 1/500.</strong></p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol.", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000", "WB-species-notes": "<p><strong>For unpurified use at 1/10000 - 1/20000.</strong></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/50 - 1/500", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/20", "FlowCytIntra-species-notes": "<p><a href='/ko/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody. For unpurified use at 1/100</p>" }, "Mouse": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/20", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000", "WB-species-notes": "<p><strong>For unpurified use at 1/10000 - 1/20000.</strong></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" }, "Rat": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000", "WB-species-notes": "<p><strong>For unpurified use at 1/10000 - 1/20000.</strong></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

제품 세부 정보

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

특성 및 보관 정보

제형
Liquid
Purification 테크닉
Affinity purification Protein A
보관 버퍼
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
배송 시 보관 조건
Conditional Ambient
적절한 단기 보관 조건
+4°C
적절한 장기 보관 조건
-20°C
보관 정보
Stable for 12 months at -20°C

제품 프로토콜

For this product, it's our understanding that no specific protocols are required. You can visit:

타겟 정보

Multifunctional protein with controversial molecular function which plays an important role in cell protection against oxidative stress and cell death acting as oxidative stress sensor and redox-sensitive chaperone and protease (PubMed : 12796482, PubMed : 17015834, PubMed : 18711745, PubMed : 19229105, PubMed : 20304780, PubMed : 25416785, PubMed : 26995087, PubMed : 28993701). It is involved in neuroprotective mechanisms like the stabilization of NFE2L2 and PINK1 proteins, male fertility as a positive regulator of androgen signaling pathway as well as cell growth and transformation through, for instance, the modulation of NF-kappa-B signaling pathway (PubMed : 12612053, PubMed : 14749723, PubMed : 15502874, PubMed : 17015834, PubMed : 18711745, PubMed : 21097510). Has been described as a protein and nucleotide deglycase that catalyzes the deglycation of the Maillard adducts formed between amino groups of proteins or nucleotides and reactive carbonyl groups of glyoxals (PubMed : 25416785, PubMed : 28596309). But this function is rebuted by other works (PubMed : 27903648, PubMed : 31653696). As a protein deglycase, repairs methylglyoxal- and glyoxal-glycated proteins, and releases repaired proteins and lactate or glycolate, respectively. Deglycates cysteine, arginine and lysine residues in proteins, and thus reactivates these proteins by reversing glycation by glyoxals. Acts on early glycation intermediates (hemithioacetals and aminocarbinols), preventing the formation of advanced glycation endproducts (AGE) that cause irreversible damage (PubMed : 25416785, PubMed : 26995087, PubMed : 28013050). Also functions as a nucleotide deglycase able to repair glycated guanine in the free nucleotide pool (GTP, GDP, GMP, dGTP) and in DNA and RNA. Is thus involved in a major nucleotide repair system named guanine glycation repair (GG repair), dedicated to reversing methylglyoxal and glyoxal damage via nucleotide sanitization and direct nucleic acid repair (PubMed : 28596309). Protects histones from adduction by methylglyoxal, controls the levels of methylglyoxal-derived argininine modifications on chromatin (PubMed : 30150385). Able to remove the glycations and restore histone 3, histone glycation disrupts both local and global chromatin architecture by altering histone-DNA interactions as well as histone acetylation and ubiquitination levels (PubMed : 30150385, PubMed : 30894531). Displays a very low glyoxalase activity that may reflect its deglycase activity (PubMed : 22523093, PubMed : 28993701, PubMed : 31653696). Eliminates hydrogen peroxide and protects cells against hydrogen peroxide-induced cell death (PubMed : 16390825). Required for correct mitochondrial morphology and function as well as for autophagy of dysfunctional mitochondria (PubMed : 16632486, PubMed : 19229105). Plays a role in regulating expression or stability of the mitochondrial uncoupling proteins SLC25A14 and SLC25A27 in dopaminergic neurons of the substantia nigra pars compacta and attenuates the oxidative stress induced by calcium entry into the neurons via L-type channels during pacemaking (PubMed : 18711745). Regulates astrocyte inflammatory responses, may modulate lipid rafts-dependent endocytosis in astrocytes and neuronal cells (PubMed : 23847046). In pancreatic islets, involved in the maintenance of mitochondrial reactive oxygen species (ROS) levels and glucose homeostasis in an age- and diet dependent manner. Protects pancreatic beta cells from cell death induced by inflammatory and cytotoxic setting (By similarity). Binds to a number of mRNAs containing multiple copies of GG or CC motifs and partially inhibits their translation but dissociates following oxidative stress (PubMed : 18626009). Metal-binding protein able to bind copper as well as toxic mercury ions, enhances the cell protection mechanism against induced metal toxicity (PubMed : 23792957). In macrophages, interacts with the NADPH oxidase subunit NCF1 to direct NADPH oxidase-dependent ROS production, and protects against sepsis (By similarity).
See full target information PARK7

대체 명칭 보기

Parkinson disease protein 7, Maillard deglycase, Oncogene DJ1, Parkinsonism-associated deglycase, Protein DJ-1, Protein/nucleic acid deglycase DJ-1, DJ-1, PARK7

제품이 사용된 논문 (51)

Recent publications for all applications. Explore the 전체 목록and refine your search

Frontiers in immunology 16:1656729 PubMed40990010

2025

Loss of DJ-1 alleviates microglia-mediated neuroinflammation in Parkinson's disease via autophagy-lysosomal degradation of NLRP3.

Applications

Unspecified application

Species

Unspecified reactive species

Qianqian Miao,Tiantian Wang,Haoran Wang,Yanxia Yu,Xing Jin

JCI insight 10: PubMed40459948

2025

Stearoyl-CoA desaturase inhibition normalizes brain lipid saturation, α-synuclein homeostasis, and motor function in mutant Gba1-Parkinson mice.

Applications

Unspecified application

Species

Unspecified reactive species

Silke Nuber,Harrison Hsiang,Esra'a Keewan,Tim E Moors,Sydney J Reitz,Anupama Tiwari,Gary Ph Ho,Elena Su,Wolf Hahn,Marie-Alexandre Adom,Riddhima Pathak,Matthew Blizzard,Sangjune Kim,Han Seok Ko,Xiaoqun Zhang,Per Svenningsson,Dennis J Selkoe,Saranna Fanning

Communications biology 7:1439 PubMed39501077

2024

STUB1 suppresses paclitaxel resistance in ovarian cancer through mediating HOXB3 ubiquitination to inhibit PARK7 expression.

Applications

Unspecified application

Species

Unspecified reactive species

Laigang Zhao,HanLin Yang,Yuanmei Wang,Shuang Yang,Qisi Jiang,Jun Tan,Xing Zhao,Dan Zi

Redox biology 72:103156 PubMed38640584

2024

Atox1 protects hippocampal neurons after traumatic brain injury via DJ-1 mediated anti-oxidative stress and mitophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Pengzhan Zhao,Wenqian Shi,Yangfan Ye,Ke Xu,Jingming Hu,Honglu Chao,ZeQiang Tao,Lei Xu,Wei Gu,Liuchao Zhang,Tian Wang,Xinyue Wang,Jing Ji

Experimental & molecular medicine 56:747-759 PubMed38531963

2024

Involvement of DJ-1 in the pathogenesis of intervertebral disc degeneration via hexokinase 2-mediated mitophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Jialiang Lin,Longjie Wang,Yuhao Wu,Qian Xiang,Yongzhao Zhao,Xuanqi Zheng,Shuai Jiang,Zhuoran Sun,Dongwei Fan,Weishi Li

Aging cell 23:e14124 PubMed38380563

2024

N-homocysteinylation of DJ-1 promotes neurodegeneration in Parkinson's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Tao Guo,Lingyan Zhou,Min Xiong,Jing Xiong,Juan Huang,Yiming Li,Guoxin Zhang,Guiqin Chen,Zhi-Hao Wang,Tingting Xiao,Dan Hu,Anyu Bao,Zhentao Zhang

Burns & trauma 11:tkad024 PubMed38116467

2023

S-Nitrosylation-mediated coupling of DJ-1 with PTEN induces PI3K/AKT/mTOR pathway-dependent keloid formation.

Applications

Unspecified application

Species

Unspecified reactive species

Dongming Lv,Zhongye Xu,Pu Cheng,Zhicheng Hu,Yunxian Dong,Yanchao Rong,Hailin Xu,Zhiyong Wang,Xiaoling Cao,Wuguo Deng,Bing Tang

Experimental and therapeutic medicine 26:463 PubMed37664676

2023

Effects of DJ‑1 on apoptosis and mitophagy of glomerular podocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Jing Xiao,Junjie Tan,Li Yu,Guosheng Liu,Shengyou Yu

Cell and tissue research 393:455-470 PubMed37450039

2023

BDNF alleviates Parkinson's disease by promoting STAT3 phosphorylation and regulating neuronal autophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Xin Geng,Yanghong Zou,Jinghui Li,Shipeng Li,Renli Qi,Hualin Yu,Lianmei Zhong

Investigative ophthalmology & visual science 63:25 PubMed36383351

2022

Type 2 Diabetes Mellitus Makes Corneal Endothelial Cells Vulnerable to Ultraviolet A-Induced Oxidative Damage Via Decreased DJ-1/Nrf2/NQO1 Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Xueling Zhang,Jini Qiu,Feifei Huang,Kun Shan,Chaoran Zhang
제품이 사용된 논문 모두 보기

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com